Cargando…
Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy
Gastric cancer is characterized by high morbidity and mortality worldwide. Early-stage gastric cancer is mainly treated with surgery, while for advanced gastric cancer, the current treatment options remain insufficient. In the 2022 NCCN Guidelines for Gastric Cancer, immunotherapy is listed as a fir...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426247/ https://www.ncbi.nlm.nih.gov/pubmed/36042469 http://dx.doi.org/10.1186/s40364-022-00413-0 |